Introduction
Lactobacillus fermentum LfME-3 has shown an antiatherogenic potential [1, 2] , but this has not yet been proven in postprandial period. The period after a meal actuates the response of an organism to food. The fat load of the meal can initiate postprandial lipemia and deepen oxidative stress, both of which have a substantial role in the progression of CVD and diabetes. Many of the possible links between oxidative stress and the metabolic syndrome occur during the postprandial period. These include excessive and prolonged elevation of blood triglyceride levels, impairment of the endothelial function, an intestinal overproduction of chylomicrons, a redundant load for insulin production, the elevation of levels of atherogenic oxidized lowdensity lipoprotein and possible disturbances in the antioxidativity of high-density lipoproteins [3] [4] [5] [6] . Thus, a positive modulation of the postprandial situation, including oxidative stress, is an important target for dietary preventive actions. Foods enriched with antioxidant probiotics may be a promising strategy.
Probiotics are defined as live microbial food ingredients beneficial to health [7] . Their benefits include improved intestinal microbial balance, reduced gut inflammation, alleviation of lactose intolerance symptoms and prevention of food allergy [8] . However, investigations of their impact on postprandial responses are absent. A few lactobacilli strains have shown physiologically relevant antioxidative potency. One of these strains is Lactobacillus fermentum ME-3 (LfME-3; DSM14241, now patented in the USA, Russia, Estonia and European Union). It is of human origin [9] and a safety-proven probiotic exhibiting both antimicrobial and antioxidative benefits under different in vitro and in vivo conditions [10] [11] [12] and having a history of safe use in foodstuffs, especially in kefir, in Finland and the Baltic countries. Encouraged by the results of our previous trials with LfME-3 [1, 2, 10, 11, [13] [14] [15] [16] we aimed to carry out a study to evaluate the effects of kefir enriched with probiotic L. fermentum ME-3 on postprandial oxidative stress, postprandial lipemic response and blood lipoprotein status when added to an ordinary diet.
Experimental Procedures

Subjects and study design
One hundred clinically healthy volunteers (75 females, 25 males, age 40-65 years) with mean BMI 30±5 kg/m 2 were recruited into a double-blind placebo-controlled randomized study. Exclusion criteria were as follows: an ongoing acute infection; diabetes; history of food allergy or gastrointestinal disease; use of any antimicrobial agent within the preceding month or use of any regular concomitant medication including non-steroidal antiinflammatory drugs, statins or hormonal contraception; pregnancy or breastfeeding; alcohol abuse; use of drugs; special diets; smoking. During the intervention, and for two weeks beforehand, participants were asked to avoid vitamin or mineral supplementation, changes in accustomed diet habits and everyday physical activity, and use of probiotic-based foods or other kefirs/yogurts. The participants were randomly divided into two groups (each of 50 participants). Unfortunately because of personal reasons and an epidemic of influenza, 25 participants of the control group and 2 participants in the study group did not finish the trial. Of those who completed the experiment, there were in the control group 18 women and 7 men with mean BMI 28±2 kg/m 2 and mean age 55±2 years; in the study group 34 women and 14 men with mean BMI 27±2 kg/m 2 , and mean age 55±3 years.
All participants signed their written informed consent and had the option of withdrawing from the study at any time. The Ethics Review Committee (ERC) on Human Research of the University of Tartu approved the study protocol. This study was carried out in accordance with the Declaration of Helsinki of the World Medical Association.
The LfKef (containing the probiotic) and Ckef (the kefir without a probiotic additive) were identical nutrient composition (including fat content, 2.5%), color, taste, and caloric value and were produced by the Tere Dairy Ltd (Tallinn, Estonia). After two weeks' introductory period, baseline standard fasting blood (from the antecubital vein) and urine samples were obtained. Postprandial blood and urine samples were obtained 2.5 h after consuming a standard breakfast (Table 1) , which was the maximum point of the postprandial response according to our previous experiments). Samples were kept at -80°C until analyzed. Participants were then randomly assigned into two groups to receive 200 ml of either the LfKef or Ckef daily for two weeks. After the two-week intervention period, postprandial (2.5 h after standard meal) blood and urine samples were obtained as well as fecal samples of that day, again after an identical standard breakfast.
The viability of LfME-3 in the LfKef was analyzed before the delivery to the study participants. Decimal dilutions of the kefir were seeded on the MRS (Oxoid Ltd. Basingstoke, UK) agar medium and incubated for 48 h at 37 o C in micro aerobic (CO 2 /O 2 /N 2 : 10/5/85) conditions (incubator IG 150, Jouan, France). The probiotic strain was identified as described previously [1, 9, 11] . The viable count of LfME-3 in the LfKef was stable in all purchased lots (viable counts 2x10 8 CFU/g kefir).
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Common biochemical analysis
The measurements of HDL-Chol, LDL-Chol and TG were performed using a routine clinical laboratory analysis (enzymatic colorimetric methods on an automatic analyzer).
Serum level of baseline diene conjugates of low-density lipoprotein (BDC-LDL)
The serum level of BDC-LDL was measured by determining the level of LDL diene conjugation using a method that has been recently validated and reported in detail [17] . In brief, serum LDL was isolated by precipitation with buffered heparin-citrate. The amount of peroxidized lipids in samples was determined by the degree of conjugated diene double bonds. Lipids were extracted from the samples by a mixture of chloroform and methanol (2:1), dried under nitrogen, redissolved in cyclohexane, and analyzed spectrophotometrically at 234 nm. For BDC-LDL, the coefficient of variance for within-assay and between-assay precision was 4.4% and 4.5%, respectively.
Plasma level of oxidized low-density lipoprotein (oxLDL)
The plasma level of oxLDL was measured using an ELISA kit (Mercodia AB, Uppsala Sweden; Cat No 10-1143-01). Mercodia Oxidized LDL ELISA is a solid phase two-site enzyme immunoassay, based on direct sandwich technique in which two monoclonal antibodies are directed against separate antigenic determinants on the oxidized apolipoprotein B molecule. During incubation and a simple washing step that removes nonreactive plasma components, a peroxidase conjugated anti-apolipoprotein B antibody recognizes the oxLDL bound to the solid phase. After a second incubation and simple washing step that removes unbound enzymelabeled antibody, the bound conjugate is detected by reaction with 3,3´,5,5´-tetramethylbenzidine. The reaction is stopped by adding an acid to give a colorimetric endpoint that is read spectrophotometrically at 450 nm by a photometer. We used the Sunrise photometer (Tecan Austria GmbH, Salzburg, Austria).
Serum level of oxLDL-β 2 glycoprotein I (Beta2-GPI-oxLDL)
The serum level of Beta2-GPI-oxLDL was measured using an ELISA kit (Cayman Chemical Company, Ann Arbor, MI, U.S.A; Cat No 10007893). Beta2-GPI-oxLDL is an enzyme immunoassay, based on a sandwich technique that detects the circulating oxLDL-β 2 GPI complex in human serum. Bound Beta2-GPI-oxLDL was detected using a horseradish peroxidase (HRP)-labeled monoclonal antibody against human apoB100.
Colorimetric detection of bound HRP-antibody conjugate was detected by reaction with 3, 3´, 5, 5´-tetramethylbenzidine. The reaction was stopped by adding acid to give a colorimetric endpoint that was read spectrophotometrically at 450 nm by a photometer . We used the Sunrise photometer (Tecan Austria GmbH, Salzburg, Austria).
Analysis of Paraoxonase (PON) activity
Blood serum samples frozen at -70°C were thawed just before the beginning of each assay. PON activity towards paraoxon was measured following the reaction of paraoxon hydrolysis into p-nitrophenol and diethylphosphate catalysed by the enzyme [18] . 
8-Isoprostanes (8-EPI) in urine
Urinary 8-isoprostanes was measured using the method previously published [1] . This assay is a competitive enzyme-linked immunoassay for determining levels of 8-EPI in biological samples (BIOXYTECH 8-isoprostane Assay, Cat. No.21019). Briefly, 8-EPI in the samples or standards competes for binding (to the antibody coated on the plate) with 8-EPI conjugated to horseradish peroxidise (HRP). The peroxidise activity results in colour development when the substrate is added. The intensity of the colour is proportional to the amount of 8-EPI-HRP bound and inversely proportional to the amount of 8-EPI in the samples or standards. The urinary concentrations of isoprostanes were corrected by urinary creatinine concentrations to account for the differences in renal excretory function. Creatinine was measured colorimetrically (Jaffe kinetic method).
Microbial DNA extraction
The fecal samples were stored at -70ºC until analyzed. Fecal samples of 20 mg were suspended in 1:10 volume of cold 1x PBS and centrifuged for 30 s at 100 x g to remove debris. Supernatants were collected and centrifuged for 5 min at 16000 x g. Pellets were washed once with 1 volume of 1x PBS and once with 1 volume of 10 mM Tris pH8, 10 mM EDTA. Fecal samples were then resuspended in 10 mM Tris pH 8, 10 mM EDTA, 10 mg/ml lysozyme and 400 u/ml mutanolysin, and incubated 15 min at 37ºC. After incubation, the fecal suspensions were transferred to screw-cap tubes containing 300 mg of zirconium beads (0.1 mm) and 1.4 ml of ASL buffer (Qiamp DNA Stool Mini Kit, Quiagen) and were beaten in a Fast Prep at 6.5 ms -1 for 3 x 45 with cooling on ice between runs. After that, samples were centrifuged for 1 min to pellet the stool particles, and DNA was then extracted from supernatants using the Qiamp DNA Stool Mini kit following the manufacturer's instructions. The presence of DNA was determined visually after electrophoresis on a 1.2% agarose gel containing ethidium bromide. To obtain DNA from the bacterial pure culture, cells from 1 ml of the culture were collected and the DNA was isolated with QIAmp DNA isolation kit (Quiagen).
Real-time PCR
Real-time PCR was performed with the ABI PRISM 7500 HT Sequence Detection System (Applied Biosystems) using optical grade 96-well plates [19, 20] . The PCR reaction was performed on a total volume of 25 μL using the SYBR Green PCR Master mix (Applied Biosystems). Each reaction included 5 μL of template DNA, 12.5 μL SYBR Green (Applied Biosystems), 0.2 μM (lac-primers), 100 nM (Lferm-primers) and 0.2 μM (ferME-primers) ( Table 2 ). The reaction conditions were 50°C for 2 min and 95°C for 10 min; followed by 40 cycles of 95°C for 15 s, 60°C for 1 min. Data analysis were conducted with Sequence Detection Software version 1.6.3, supplied by Applied Biosystem.
Calculation of lactobacilli cell numbers
Conversion of the amount of Lactobacillus DNA in fecal samples determined by real-time PCR to theoretical genome equivalents required the assumption that the genome size and 16S rRNA gene copy number for all lactobacilli was similar. From the review by Klaenhammer et al. [21] of current and completed Lactobacillus genomic sequencing projects, the average genome size for human lactobacilli was 2.2 Mb, the average genome of L. fermentum is 2.1 Mb, so that each cell contains approximately 2.3-2.4 fg of DNA.
Statistical analysis
Calculations were performed using commercially available statistical software packages (Statistics for Windows, Stat Soft Inc. and Graph Pad PRISM Version 2.0) and software R, version 1.6.0 for windows (www.r-project.org). All values are given as mean and standard deviation (mean±SD). Statistically significant differences between the groups were determined by using Student`s t-test. In all analyses, P values <0.05 were considered to be statistically significant. Correlations between the variables were examined using linear regression analysis (software R, version 2.0.1 for Windows).
Results
Three different OxS-related parameters of the LDL (BDC-LDL, oxLDL and Beta2-GPI-oxLDL) decreased significantly in the LfKef group ( Table 3) . The concentrations of oxLDL and BDC-LDL did not change in the Ckef (control) group.
Neither LfKef nor CKef had a significant effect on postprandial LDL-Chol level or on total cholesterol level. Consumption of LfKef was associated with a statistically significant increase in postprandial HDL-Chol concentrations (1.36±0.28 and 1.50±0.35 mmol/L, respectively) and in PON activity (110.0±39.5 and 133.4±38.7 U/L, respectively). The elevated PON activity is probably a HDL-linked PON as a correlation model revealed statis tically significant positive corre lation bet ween the concentration of HDL-Chol and PON (Figure 1) . Consumption of the LfKef reduced the postprandial lipaemic response measured by the blood triglyceride levels 2.1±1.1 to 1.9±0.7 mmol/l, P<0.05, while there was no change in the case of CKef (2.2±0.6 and 2.6±1.1 mmol/l). There was no statistical difference between baseline values.
Primer/Target
Nucleotide sequence (5'-3') References
Lac-F / Lactobacillus GCAGCAGTAGGGAATCTTCCA [19] Lac-R / Lactobacillus GCATTYCACCGCTACACATG [19] Lferm-R / L. fermentum GTCCATTGTGGAAGATTCCC [20] Lferm-F / L. fermentum GCACCTGATTGATTTTGGTCG [20] FerME-F / L. fermentum ME-3 CCCAGCAAACTCCACCAGACA [16] FerME-R / L. fermentum ME-3 TGTGGAATTGTGAGCGGATA [16] The systemic OxS marker, urinary 8-EPI, was not significantly different in the LfKef and Ckef groups before intervention, but after two weeks of LfKef consumption the concentration of 8-EPI had decreased from 37.7±7.6 to 28.8±6.1 ng/mmol creatinine (P=0.0001, Figure 2 ). There was no change with consumption of the Ckef (37.0±8.0 and 38.1±6.5 ng/mmol creatinine respectively). Consumption of LfKef was not associated with a significant change in the total fecal lactobacilli count (baseline 6.7±1.0 log 10 cfu/g feces, post-intervention 7.1±1.1 log 10 cfu/g feces) ( Figure 3 ). All subjects in the Lfkef group harbored lactobacilli during the trial. The concentration of L. fermentum species was quite low at baseline (3.7±1.7 log 10 cfu/g feces) and significantly increased(4.7±1.4 log 10 cfu/g feces, p=0.008). Also, the concentration of the specific strain L. fermentum ME-3 increased (1.7±1.0 vs. 3.7±1.7 log 10 cfu/g feces, P=0.018).
LfKef (n=48)
CKef ( 
Discussion
Postprandial lipemic response is widely accepted as an independent risk factor for CVD. Any aggravation of the postprandial pro-oxidative situation may have negative consequences as postprandial oxidative stress (OxS) has been suggested to be the unifying mechanism in the connection between CVD, metabolic syndrome, insulin resistance and Type 2 diabetes [4, 22] . Both postprandial lipemic response and aggravation of postprandial OxS have a direct impact on blood lipoprotein status and metabolism, making postprandial abnormal events crucial factors in the development of CVD [23] . Therefore nutritional changes alleviating the postprandial load of OxS, postprandial blood triglyceride (TG) response and lipoprotein status may have a preventing impact on the development of CVD. For example, recently it has been shown that short-term intake of the Mediterranean diet and an acute intake of an olive oil meal lead to the formation of a reduced number of higher-size triacylglycerols-rich lipoproteins compared with another fat source [6] . Therefore, considering the principal roles of the postprandial OxS and lipemic response, and our previous trials with LfME-3 [1,2,11,13] we carried out a study to evaluate the effects of the LfKef on postprandial OxS, postprandial lipemic response and blood lipoprotein status. Our main findings were that consumption on the LfKef reduced the postprandial lipemic response, decreased the body systemic OxS-load (lower level of isoprostanes), decreased the level of oxidized LDL (measured by three different methods) and elevated the levels of HDL and HDL-related PON activity. The LfKef did not have significant influence on the post prandial LDL-Chol level or the total cholesterol level.
Postprandial hypertriglyceridemia can cause endothelial dysfunction that is recognized as an early process of atherosclerosis even in healthy subjects [3] . Both OxS and blood lipoprotein status are related to the development of CVD. Recently it was noted that the traditional CVD risk factors, in promoting OxS and endothelial dysfunction, are the first steps in a cascade of pathological events [24] . OxS leads to an excess of oxLDL and the higher levels of the circulating oxLDL, even more than LDL-Chol, are strongly associated with the increased incidence of metabolic syndrome in people who are young and otherwise healthy [25] . OxLDL is an important determinant of structural changes of the arteries even in asymptomatic persons [13, 26] . Recent data suggest that an increased production of atherogenic and inflammatory oxLDL within the vessel wall suppresses several immunity-related cells, including regulatory T cells [27] which normally exert antiatherogenic and anti allergic effects. It should be noted that previous trials have shown the positive effect of ME-3 on blood LDL, prolonging its resistance to oxidation, lowering the content of oxLDL and BDC-LDL and enhancing the total antioxidative capacity of the blood [1, 11, 14] . The systemic influence of LfME-3 on the host´s OxS-load is seen in the decline of the values of isoprostanes, which are accepted as an informative marker for the body's systemic OxS-burden [28] . It seems that the systemic effect of LfME-3 starts by alleviating OxS-and inflammation-related abnormalities in the intestinal cells, leading to altered composition of lipoproteins (chylomicrons, VLDL, LDL and HDL) with lower levels of harmful oxidation products. Improvement of the luminal environment of the gastrointestinal (GI) tract as well as within the intestinal cells, by improving glutathione levels and decreasing lipid peroxidation has been confirmed by Truusalu [29, 30] in a mouse experimental S. typhimurium infection. Involvement of the glutathione system is fundamental as reduced glutathione (GSH) is both a crucial antioxidant and a principal redox-controller for a number of processes in cells. Some lipid hydroperoxides in food may escape from reduction by glutathione peroxidase in the GI tract and enter the circulation [31] . Consumption of antioxidant probiotic LfME-3, which produces glutathione and has complete glutathione redox cycle enzymes (Gp x and GRed), may contribute to the reduction of lipid hydroperoxides in the GI tract and in hepatocytes and prevent them from entering the circulation [32] .
The antioxidant activity of HDL can be expressed through multiple mechanisms [33] . PON is an antioxidant enzyme associated with HDL in human serum that hydrolyzes oxidized phospholipids and inhibits the LDL oxidation that is otherwise an important step in atherogenesis. In animals, the addition of oxidized lipids to the circulation reduces PON activity, and diets rich in oxidized fat accelerate the development of atherosclerosis [34] . Removal and inactivation of lipid peroxides which accumulate during LDL oxidation may be the central mechanism accounting for HDL antioxidative properties [35] . Recent studies have shown that when HDL particles have poor bioquality (antioxidant properties and anti atherosclerotic potency), they may have even inflammatory effect [35] . Indeed, the antioxidant action of HDL is recognized as one of the principal mechanisms mediating its cardioprotective effect [36] . The increase in PON activity by LfKef consumption shows that protection of plasma lipo protein particles against oxidative modification by ROS is improved. PON inhibits athero ge nesis by hydrolyzing lipid hydroperoxides and cho lesterol ester hydroperoxides, reducing pero xides to the hydroxides, and hydrolyzing homo cycteine thiolactone which prevents protein homo cycteinylation [37, 38] . Thus, an elevation of PON activity should decrease the level of oxLDL. We have established statistically signi ficant nega tive correlation bet ween the PON activity and oxLDL.
As established in a murine model of S. typhimurium infection (article in press), the antioxidant probiotic LfME-3 may interfere with the postprandial status of lipoprotein metabolism by increasing the production of the anti-inflammatory cytokine IL-10 and by decreasing the production of the pro-inflammatory cytokine TNF-α in ileal mucosa and hepatocytes, hence lowering levels of VLDL and TG and reducing formation of oxLDL. Changes in VLDL production can be due to changes in the amount of lipid per VLDL particle, the number of particles secreted, or both.
According to our previous data, fecal recovery of LfME-3 is detectable after consumption of probiotic yoghurt, cheese and kefir. LfME-3 fecal recovery was particularly good when this strain was consumed with fermented goat milk containing only 2 starter strains with ME-3 as a probiotic adjunct [1] . The food vehicle for the probiotic in the present study was kefir and resulted in a significant increase in the fecal concentration of the overall L. fermentum (that includes LfME-3). It seems that kefir may be a less ideal vehicle for ME-3 compared with fermented goat´s milk. Though ME-3 tolerates technological handling well, surviving the kefir production and remaining viable during the shelf-life, the interactions of ME-3 with the microbial species in the kefir grain and their effect on ME-3 viability are not clarified yet.
Thus, every study opens addi tional aspects and has certain limitations but it is note worthy that our pilot study is the first to explore the possibility that a traditional foodstuff enriched with a special probiotic may have a significant positive impact on postprandial lipemic response, OxS and lipoprotein status. Thus, this information is worth further investigation using large scale studies.
